Building Blocks for COVID-19 Antiviral Drugs Identified in Rapid Study
Scientists have identified key chemical building blocks for an eventual antiviral drug against SARS-CoV-2, the virus that causes COVID-19.
University of California San Francisco
Give to UCSF
Special Notice Concerning COVID-19
Learn about UCSF’s response to the coronavirus outbreak, important updates on campus safety precautions, and the latest policies and guidance on our COVID-19 resource website. You can also access information from the CDC. Learn more
COVID-19 Relies on Cell’s ‘Master Regulators’ for Survival
UCSF scientists assembled an international research team that has figured out how SARS-CoV-2, the virus that causes COVID-19, hijacks proteins in host cells that serve as master regulators of key cellular processes.
Nature Publication Presents New ‘Blueprint’ Revealing How SARS-CoV-2 Virus Hijacks Human Cells
An international team of more than 120 scientists has detailed the impact of 75 over-the-counter prescription and development-stage drug compounds on SARS-CoV-2, the virus that causes COVID-19.
Confronting COVID-19: Donors’ Generosity Put to Use at Lightning Speed Across UCSF
Vigorously embracing their leadership roles, our faculty members are coming together to tackle this public health crisis from all angles.
Unveiling How Coronavirus Hijacks Our Cells to Help Rush New Drugs to Patients
Though many hopes are hanging on the development of a vaccine or drug that targets the novel coronavirus directly, a UCSF-led team is taking an unconventional approach: target the host – in other words, you.
Acid Reflux Drug Is a Surprising Candidate to Curb Preterm Birth
The study also identified 12 other FDA-approved drugs that are deemed safe in pregnancy.
HPV and Tobacco Induce Cancer Through Common Pathways
These results confirm that the HPV virus causes head and neck cancer by inactivating the same proteins that are mutated in smoking-induced cancer.
NIH Funds UCSF-led Initiative to Chart a Course Toward New Psychiatric Drugs
Researchers at UCSF and the Gladstone Institutes have received an $18 million grant from the National Institutes of Health to launch the Psychiatric Cell Map Initiative.
Combination Therapy May Revive Prospects for ‘Embattled’ Breast Cancer Drugs
Researchers identified a protein that cancer cells use as a shield to protect the PI3K pathway against targeted drugs, and showed that blocking this protein allowed previously ineffective therapies to slow cancer cell growth and shrink tumors.
Gene Mapping Lays Groundwork for Precision Chemotherapy
New study could make it much easier for physicians to use the genetic profile of a patient’s tumor to pick the chemotherapy treatment with the fewest side effects and best chance of success.
Big-Data Analysis Points Toward New Drug Discovery Method
A research team led by scientists at UCSF has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs.
New Tool Illuminates Cell Signaling Pathways Key to Disease
In a major advance for fundamental biological research, UCSF scientists have developed a tool capable of illuminating previously inscrutable cellular signaling networks.
How Computers are Searching for Drugs of the Future
Researchers at UCSF and elsewhere are turning to virtual experiments for the initial steps of drug development.
Deworming Pill May Be Effective in Treating Liver Cancer
UCSF researchers have used data-mining computational tools to identify a treatment for hepatocellular carcinoma, a cancer associated with underlying liver disease and cirrhosis that often only becomes symptomatic when it is very advanced.
AB 2664 Supports Innovation, Entrepreneurship at UC
A $22 million investment via California State Assembly Bill 2664 is supporting innovation and entrepreneurship at UC San Francisco and across the University of California system.
